JP Morgan Raises UnitedHealth (UNH) Price Target to $524

JP Morgan has reaffirmed its Overweight rating on UnitedHealth Group with a new price target of $524 as of October 16, 2026, a 30.54% upside from the current price.

By EarningsIQ Research Desk · Published Oct 16, 2026, 1:55 PM EDT · Updated Oct 16, 2026, 8:15 PM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

JP Morgan raised its price target on UnitedHealth Group Incorporated ($UNH) to $524 from $516 on October 16, 2026, and rates the stock "Overweight".

UNH UnitedHealth Group Incorporated

$401.43 +21.69% year to date

Daily close · Oct 16, 2026

Key Points

JP Morgan has maintained its Overweight rating on UnitedHealth Group and increased the price target from $516 to $524.
JP Morgan's $524 price target implies 30.54% upside from UnitedHealth Group Incorporated's ($UNH) current $401.41 share price.
As of October 16, 2026, UnitedHealth Group's stock is trading at about $401.79, which is 15.8% below the mean price target of $477.04.
The company has a market cap of approximately $365 billion and a P/E ratio of 26.15.

Get $UNH trade alerts by text

We text you when insiders, Congress or big funds trade $UNH. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated UnitedHealth Group Incorporated alert may contain errors. Disclosures

JP Morgan has reiterated its Overweight rating on UnitedHealth Group Incorporated (NYSE: UNH) and raised its price target from $516 to $524 on October 16, 2026. The stock was recently trading at $401.79, indicating it is below this new target.

Analyst rating track record

JP Morgan vs. the S&P 500

YTD return -1.44% hypothetical

All-time return -1.44% S&P 500 +0.45%

vs. S&P 500 -1.89% behind the index

Hypothetical returns from JP Morgan's disclosed trades, not real profit or advice. How we model this.

Other Institutional Activity in UnitedHealth Group

Several other institutional investors have also shown interest in UnitedHealth Group. Blackrock Inc. holds 76,863,061 shares valued at about $30.9 billion, after increasing its stake by 3,394,259 shares. Vanguard Capital Management LLC has 59,311,525 shares worth approximately $23.8 billion, with a slight increase of 441,525 shares. State Street Corporation owns 45,633,267 shares valued at about $18.3 billion, after adding 299,205 shares. Capital World Investors has 29,887,932 shares worth around $12.0 billion, having increased its stake by 2,103,297 shares. FMR, LLC has the smallest share count among these institutions, with 27,992,995 shares valued at $11.2 billion, significantly increasing its holdings by 15,974,192 shares.

UnitedHealth Group Incorporated Stock Up 1.5%

UnitedHealth Group's stock is trading above its 50-day moving average by about 3.7% and above its 200-day moving average by 12.0%. However, it is trading 15.8% below the mean price target of $477.04 and 13.0% below its 52-week high of $461.62. The stock is notably above its 52-week low of $255.97 by 57.0%.

12-month forecast

$UNH price target

UnitedHealth Group Incorporated daily closes and this analyst's $524 target. Not advice.

Recent Earnings

In its most recent earnings report, UnitedHealth Group reported trailing twelve-month revenue of approximately $450.1 billion and earnings per share (EPS) of $15.55. The company's return on equity (ROE) stands at 15.8%, while its net margin is 3.5%. The next earnings report is scheduled for January 26, 2027.

Insider Buying and Selling at UnitedHealth Group Incorporated

Insider trading activity includes Officer Patrick Hugh Conway selling 500 shares at an average price of $410.00 on August 5, 2026, for a total value of $205,000. He also sold 1,169 shares at an average price of $390.00 on August 21, 2026, totaling $455,910. Both transactions occurred before the recent analyst ratings.

Analysts Set New Price Targets

On the same day as JP Morgan's announcement, Bernstein maintained its Outperform rating with a price target of $500, down from $512. Earlier, on October 14, Piper Sandler maintained an Overweight rating with a target of $504, while Barclays also maintained its Overweight rating with a target of $440. On October 15, TD Cowen reiterated its Hold rating with a target of $402.

About UnitedHealth Group

UnitedHealth Group Incorporated operates in the healthcare sector, providing a range of services through segments like Optum Health and UnitedHealthcare. The company focuses on care delivery, management, and health financial services, catering to various stakeholders, including patients and public-sector entities. This recent rating from JP Morgan highlights continued confidence in the company's performance amid a challenging market.

Bottom Line

Investors should monitor UnitedHealth Group's upcoming earnings report on January 26, 2027, and watch for any further analyst updates following this reiteration from JP Morgan. The stock's current position below analyst targets may present opportunities for investors looking at long-term prospects.